Betagistin | Betagistin tablets 24 mg 60 pcs.

Packaging

60 pcs

Pharmacological action

Betagistin - histaminergic, improves microcirculation.

Pharmacodynamics

Agonist of the H1 receptors of the vessels of the inner ear and an antagonist of the H3 receptors of the vestibular nuclei of the central nervous system.

By direct agonistic action on the H1 receptors of the vessels of the inner ear, as well as indirectly through the action on the H3 receptors, it improves microcirculation and capillary permeability, normalizes endolymph pressure in the labyrinth and cochlea, and increases blood flow in the basilar artery.

It has a pronounced central effect, being an inhibitor of the H3 receptors of the vestibular nerve nuclei. It improves the conductivity in the neurons of the vestibular nuclei at the level of the brain stem.

The clinical manifestation of these properties is a decrease in the frequency and intensity of dizziness, decrease in tinnitus, improvement in hearing if it is reduced.

Pharmacokinetics

Absorbed rapidly, binding to plasma proteins is low. The time required to reach Cmax is 3 hours.

It is almost completely excreted by the kidneys in the form of a metabolite (2-pyridylacetic acid) within 24 hours. T1 / 2 - 3-4 hours.

Indications

treatment and prevention of vestibular dizziness of various origins

syndromes, including dizziness and headache, tinnitus, progressive hearing loss, nausea and vomiting

disease or Meniere's syndrome.

Use during pregnancy and lactation

Insufficient data to evaluate the effects of the drug during pregnancy and lactation.

In this regard, it is not recommended to take during pregnancy. At the time of treatment, it is necessary to stop breastfeeding.

Ingredients

1 tablet contains:

Active ingredient:

betahistine dihydrochloride 24 mg

Excipients:

MCC

lactose (milk sugar)

citric acid srdlcdl silicon dihydrochloride

Dosage and Administration

Inside, with meals. 1 / 2-1 tablets 3 times a day.

Improvement is usually noted already at the beginning of therapy.

A stable therapeutic effect occurs after two weeks of treatment and can increase over several months of treatment.

Treatment is long. The duration of the drug is selected individually.

Side effects

Gastrointestinal disorders, allergic reactions from the skin (skin rash, itching, urticaria), Quincke edema.

Drug Interaction

Cases of interaction or incompatibility with other drugs are unknown.

Overdose

Symptoms: nausea, vomiting, convulsions.

Treatment: gastric lavage, activated carbon intake, symptomatic therapy.

Storage conditions

Store in a dry place out of the reach of children, protected from light, at a temperature not exceeding 25 РC.

Expiration

2 Year

Deystvuyuschee substances

betahistine

s171products for pharmacy

prescription and prescription

pharmacy for prescription p1719 vocational

dosage form

dosage form

tablets

Vertex, Russia